Related Experiment Videos

[Clinical studies on panipenem/betamipron in pediatrics]

T Sekiguchi1, T Okamoto, K Ohara

  • 1Department of Pediatrics, Takamatsu Red Cross Hospital.

Insights

Panipenem/betamipron (PAPM/BP) effectively treated pediatric bacterial infections, including pneumonia and skin infections. The antibiotic showed high clinical response and bacterial eradication rates with minimal side effects in children.

Area of Science:

  • Pediatric Infectious Diseases
  • Antibiotic Therapy
  • Pharmacology

Background:

  • Acute bacterial infections pose significant health risks in children.
  • Effective and safe antibiotic options are crucial for pediatric care.
  • Panipenem/betamipron (PAPM/BP) is an antibiotic combination for bacterial infections.

Observation:

  • A study evaluated PAPM/BP in 15 children with acute bacterial infections.
  • Infections included acute pneumonia, staphylococcal scalded skin syndrome, and urinary tract infections.
  • Treatment involved 30-minute drip infusions of PAPM/BP.

Findings:

  • All 15 pediatric patients achieved good to excellent clinical responses.
  • Bacterial eradication was confirmed for all 12 identified bacterial strains.
  • One patient experienced urticaria; mild GOT/GPT elevations and eosinophilia were noted in separate cases.

Implications:

  • PAPM/BP demonstrates significant efficacy in treating diverse pediatric bacterial infections.
  • The antibiotic is well-tolerated, with a favorable safety profile in the pediatric population.
  • PAPM/BP represents a valuable therapeutic option for pediatric infectious disease management.

Related Concept Videos